Cancer

Researchers Identify Best Drug Therapy for Rare, Aggressive Pancreatic Cancer

Each year, about 200 to 400 Americans develop acinar cell carcinoma, a rare form of pancreatic cancer that has no effective standard of care.

Publish Date: 6/10/2016

Minimally Invasive Inguinal Lymph Node Dissection (MILND)

James W. Jakub, M.D., demonstrates the safe, feasible operative technique of minimally invasive inguinal lymph node dissection (MILND) in a patient with melanoma.

Publish Date: 4/28/2015

Faster Tumor Analysis Software Speeds Cancer Discoveries

With the glut of data generated through next-generation sequencing, interpretation has become the new bottleneck in scientific discovery and clinical application.

Publish Date: 10/8/2014

Methylated DNA Markers and Whole Body Cancer Screening

John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in patients’ gastrointestinal tracts by analyzing DNA markers from tumors.

Publish Date: 8/5/2015

Ibrutinib With Chemotherapy Offers Longer Life to Patients With B-Cell Cancers

Researchers found that a combination of ibrutinib and chemotherapy reduced the risk of death or cancer progression by 80 percent in patients with previously treated chronic lymphocytic leukemia.

Publish Date: 8/5/2015

play 1 2 3 4 5

All
Cancer
(88)

video
PROMOTE: Prostate Cancer Medically Optimized Genome Enhanced Therapy Study

The Prostate Cancer Medically Optimized Genome Enhanced Therapy Study (PROMOTE) aims to individualize treatments for men with castration-resistant prostate cancer.

View Video

video
Minority Disparities Evident in Prostate Cancer Survival Rate, Mayo Clinic Study Shows

A Mayo Clinic study reviewed data on more than 290,000 men with prostate cancer from the past 20 years and found that African-American men are at increased risk for poorer survival rate following prostate cancer treatment compared to other minority groups.

View Video

video
Precursor of Multiple Myeloma More Common in Blacks than Whites, Mayo Study Finds

Blacks may be twice as likely as whites to develop multiple myeloma because they are also more likely to have a precursor condition known as monoclonal gammopathy of undetermined significance.

View Video

video
Study Shows Potential to Prevent Hospitalizations in Brain Tumor Patients

In a retrospective five-year study, researchers at the Mayo Clinic found that common causes of hospitalization for patients with malignant brain tumors, such as seizures, are potentially preventable.

View Video

video
Mayo Clinic Researchers Help to Shine New Light on Bladder Cancer Tumors

Mayo Clinic Researchers Help to Shine New Light on Bladder Cancer Tumors.

View Video

video
Canadian Study: Screening Mammograms Do Not Cut Breast Cancer Deaths

A study published today in the journal BMJ says annual screening mammograms in women aged 40-59 do not reduce deaths from breast cancer any better than a physical examination or usual care.

View Video

video
Mayo Clinic Scientists Propose a Breast Cancer Drug for Bladder Cancer Patients

Amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors.

View Video

video
Chemo After Radiation Therapy Improves Brain Cancer Survival

A clinical trial co-led by Mayo Clinic Cancer Center researchers found that adding chemotherapy following radiation treatment improved survival for adults with low-grade gliomas by more than five years.

View Video

Refer a patient

  1. Arizona
    866-629-6362
  2. Florida
    800-634-1417
  3. Minnesota
    800-533-1564

Online referrals

Referring your patient

Download a referral form